Download FREE Report Sample
Download Free sampleBuprenorphine hydrochloride injection?is indicated for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate.
Buprenorphine Hydrochloride Injection Market contains market size and forecasts of Buprenorphine Hydrochloride Injection in global, including the following market information:
Global Buprenorphine Hydrochloride Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Buprenorphine Hydrochloride Injection Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Buprenorphine Hydrochloride Injection companies in 2021 (%)
The global Buprenorphine Hydrochloride Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.3mg / mL Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Buprenorphine Hydrochloride Injection include Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs and Sun Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Buprenorphine Hydrochloride Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Buprenorphine Hydrochloride Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Buprenorphine Hydrochloride Injection Market Segment Percentages, by Type, 2021 (%)
0.3mg / mL
0.3mg / mL
Global Buprenorphine Hydrochloride Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Buprenorphine Hydrochloride Injection Market Segment Percentages, by Application, 2021 (%)
Analgesic
Opioid Antagonist
Global Buprenorphine Hydrochloride Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Buprenorphine Hydrochloride Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Buprenorphine Hydrochloride Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Buprenorphine Hydrochloride Injection revenues share in global market, 2021 (%)
Key companies Buprenorphine Hydrochloride Injection sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Buprenorphine Hydrochloride Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Siegfried
Sanofi
Johnson Matthey
Mallinckrodt
Noramco
Unichemlabs
Arevipharma
Resonance-labs
Sun Pharma
Rusan Pharma
Micro Orgo Chem
Faranshimi
Teva
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
